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Abstract
This paper runs through key progresses in epidemiology, pathomechanisms and therapy of various diseases in
children that were issued in the Italian Journal of Pediatrics at the end of last year. Novel research and documents
that explore areas such as allergy, critical care, endocrinology, gastroenterology, infectious diseases, neonatology,
neurology, nutrition, and respiratory tract illnesses in children have been reported. These observations will help to
control childhood illnesses.
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Introduction
This review reports key advances in allergy, critical care,
endocrinology, gastroenterology, infectious diseases,
neonatology, neurology, nutrition, and respiratory tract
illnesses in children. Articles have been identified among
the most accessed manuscripts issued in the Italian Jour-
nal of Pediatrics in the second semester of 2019.
Allergy. 1- chronic urticaria; 2- cow’s milk allergy;
3- type 1 asthma
Chronic urticaria continues to have a high prevalence in
children [1], but knowledge about management is low in
real-life [2]. The updated guideline for clinical manage-
ment of chronic urticaria in children [3] is intendent to
facilitate physicians’ work. Progresses that has been
made in understanding the pathophysiology have been
focused. The guideline underlines that chronic urticaria
is diagnosed by history, examination, and specific inves-
tigations and it also provides a diagnostic algorithm. Re-
garding treatment, second generation anti-H1
antihistamines are the treatment of choice and the
addition of corticosteroids may improve control of ex-
acerbation [4]. Novel approaches such as omalizumab,
have been found to be highly effective and safe [5].
Further developments are pertinent to allergy. Cow’s
milk protein allergy is the most common food allergy in
young children, especially those who suffer from atopic
dermatitis [6] while allergy to fruits and vegetables is the
more frequent in school children [7]. History, skin tests,
oral food challenge and specific IgE antibody measure-
ment are used for the diagnosis [8, 9]. The standard
treatment is based on avoidance of offending food and
education about treatment of reactions. Cow’s milk has
essential nutritional properties, especially for infants.
Thus, adequate substitutes are warranted. Extensive hy-
drolysate of cow’s milk proteins or rice, and amino acid
formulas are hypoallergenic and ensure growth and de-
velopment. Soy formulas can be considered after 6
months of age. However, less expensive, and more palat-
able formulas would welcome. Some mammalian milks
with better taste have been proposed as infant formulas,
but they are not recommended because of nutritional
concerns. Among them, donkey’s milk has weak clinical
cross-reactivity with cow’s milk proteins, but it is costly
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and hypocaloric with a high mineral content compared
to human milk. Sarti et al. [10] looked at a novel ap-
proach. They performed oral challenges with donkey’s
milk in 70 children with IgE-mediated cow’s milk allergy
aged 6 months − 18 years of age and 11 with food
protein-induced enterocolitis syndrome (FPIES) to cow’s
milk age range 3months – 8 months. Only one child
with IgE-mediated cow’s milk allergy reacted. Sixteen
out of the 70 patients with IgE- cow’s milk allergy and 6
out of the 11 patients with FPIES to cow’s milk followed
a diet with donkey’s milk and adequate supplements in-
cluding lipids and Vitamin D. All patients had normal
growth, a valuable addition to current knowledge.
Precision medicine targets the mechanisms (endo-
types) of allergic diseases. In asthma, the precision ap-
proach is based on monoclonal antibodies [11] and
allergen specific immunotherapy [12]. Giovannini et al.
[11] compared omalizumab and mepolizumab. They are
monoclonal antibodies used in type 2-high asthma [13].
Omalizumab is a humanized monoclonal IgG antibody
binding the circulating IgE for children with moderate -
severe persistent allergic asthma to perennial aeroaller-
gens that is not controlled with inhaled corticosteroids
and long-acting inhaled β2-agonist. It is useful also when
seasonal pollens [14] induce exacerbations [11]. Mepoli-
zumab is a humanized monoclonal IgG antibody binding
IL-5 for add-on treatment in asthmatics with elevated
blood eosinophils count. Efficacy and safety of omalizu-
mab and mepolizumab did not differ significantly.
Mepolizumab is effective in asthmatics who did not pre-
viously responded to omalizumab. More comparative
data on their efficacy, long-term safety, cost/benefit ratio
in children who are eligible for both drugs, are needed.
Critical care. 1- dental trauma; 2- pain
The incidence/year of dental trauma in children is 4.5%. It
might occur in many different settings: home, school, sport
settings or during free-time activities. So, it is necessary for
pediatricians, teachers, sport staff to have guidelines to
properly manage facial trauma in children. The updated
Italian guideline [15] provides indication about prevention
of dental trauma, diagnosis approach, management, and
medico-legal implications. The correct approach in orofa-
cial and dental trauma includes a physical examination, es-
pecially intra and extra-oral examination. When a bone
fracture is suspected, the radiological investigation of the fa-
cial district is necessary to confirm or exclude the fracture.
Therapeutic approach is multidisciplinary: maxillofacial
surgeon and dentist depending on the facial district in-
volved. Nevertheless, an urgent first aid must be guaranteed
to avoid adverse outcome. Prognostic factors need to be
carefully reported at both initial consultation and during
the follow up visits [16]. Attention must be paid also to
medicolegal aspect of the injury; a certificate of dental
trauma should be appropriately filled. Moreover, when den-
tal injury is suspected to be the result of an abuse or vio-
lence against children, it must be reported to authorities. In
a recent study, Bossù et al. [17], evaluated the application of
National guidelines for prevention and clinical management
of traumatic dental injuries in developmental age and found
that they are not uniformly applied. If prevention strategies
are correctly applied, many dental injuries might be
avoided, moreover, a proper management of trauma can
improve the outcome.
Virtual reality (VR) is a computer-generated simulat-
ing experience designed to make it as real as possible.
Fields of application include entertainment and educa-
tional purposes such as video games and surgery or mili-
tary training. In terms of clinical application, VR has
also been investigated as a therapeutic tool, in particular
for treating phobias, social disorder, and pain. Iannicelli
et al. [18] analysed the efficacy of VR as an instrument
for pain reduction in children and adolescents. Although
there are a few publications in this field, VR seems to be
effective for non-pharmacological pain reduction. In last
years, several studies investigated the use of VR for redu-
cing acute pain during various medical procedures, while
there are no studies regarding chronic pain and only one
case report [19] described the use of VR in palliative
care. Along this line, Eijlers et al. [20] has published the
first systematic review and meta-analysis specifically fo-
cused on VR in pediatric patients showing that VR di-
minished patient-reported pain and anxiety during a
range of medical procedures. Despite the use of VR in
reducing pain in pediatric patients seems encouraging,
more studies, both on acute and chronic pain, are
needed to better define his possible role in standard
care. Moreover, commercial products lack variety and
meaningful design strategies [21]. The collaboration with
VR designers would be of interest to create applications
tailored for children.
Endocrinology. 1- growth hormone; 2- turner
syndrome; 3- preterm growth
Growth impairment is a common feature in mucopoly-
saccharidoses patients, regardless of type or severity.
There is a however a continuous spectrum of phenotypic
expression from the very severe to the mild, with vari-
able ages of onset and rates of progression. Moreover,
the adult height attained depends on phenotype severity
[22]. Growth impairment seems due to the deposition of
glycosaminoglycans in bone and cartilage which leads to
progressive damage in cartilage that in turn reduces
bone growth by destruction of the growth plate and in-
complete ossification. However, the mechanism behind
short stature is not completely known. Structurally, skel-
etal abnormalities limit longitudinal growth and final
height, but alone cannot explain short stature [23].
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Standard therapy based on enzyme replacement therapy
and hematopoietic stem cell transplantation can improve
the progression of the disease, particularly when started
at young age, but its effect on the growth seems to be
limited. It would therefore be useful to find ways to im-
prove adult stature. Human growth hormone (hGH)
therapy in unselected patients has not been proven to be
effective [23]. However, in a case series of mucopolysac-
charidoses patients of different type with growth hor-
mone deficiency (GHD) Cattoni et al. [24] concluded
that hGH therapy appears to have effectively reverted
the growth deceleration, at least during the first 12–24
months of treatment without any evident side effects.
Various points derive from this interesting study which
deserve to be further investigated. In particular: a) what
is the prevalence of GHD in the different forms of
mucopolysaccharidoses? In the experience of these Au-
thors, it appears to be high involving 6 out of 64 pa-
tients; b) what is the mechanism of involvement of the
GH-IGF-1 axis? It is interesting to note that the scarce
data available are contradictory, indicating, for example,
in Hurler’s syndrome, a high GH value in more than half
of the patients [25]; c) how the hypothalamus-pituitary
axis of different hormones may be involved? Gonado-
tropin axis could be altered as demonstrated by lack of
puberty in some patients [25]; d) what is the influence
on the final height of the response to GH therapy? e)
what is the long-term safety? In conclusion, the experi-
ence of Cattoni et al. [24] stimulates us to investigate
the changes that mucopolysaccharidoses can produce at
the endocrine level and to better identify patients who
could benefit from GH therapy. On the other hand it is
important to remember that other therapeutic ap-
proaches are in the experimental phase such as the re-
cent report of a positive effect in the experimental
animal of the addition of C-type natriuretic peptide to
enzyme replacement therapy.
The report by Chen et al. [26] of a second trimester
intrauterine foetal demise of a foetus with septated nu-
chal lymphatic hygroma and hydrops fetalis, in which a
45XO karyotype was highlighted, allows to underline
some aspects of interest for clinical practice:
– The cystic hygroma of the neck is a malformation
due to an accumulation of fluid in the lymphatic
vessels and jugular sacks due to an altered
connection between the lymphatic and venous
systems. It is mono or multiloculated and is
diagnosed with sonography already in the first
trimester of pregnancy
– Prenatal cytogenetic analyzes showed in 30–60% of
cases the association with aneuploidy and in
particular with 18 and 21 trisomies and with Turner
syndrome. According to some experiences,
aneuploidy is more frequent with septated than non-
septated cases [27].
– In cases with normal karyotype there are still major
malformations, especially cardiac but also urogenital,
skeletal, nervous system and body wall anomalies in
up to one-third of foetuses. Furthermore, by
genomic microarray, it was found that in 5% of
foetuses there is a pathogenic genomic imbalance
and the most frequently found is 22q11.2 named
DiGeorge syndrome [28]. Finally, some AA
recommend prenatal testing of PTPN11, KRAS and
RAF1 in pregnancies with an increased NT and at
least one of the following additional features:
polyhydramnios, hydrops fetalis, renal anomalies,
distended JLS, hydrothorax, cardiac anomalies, cystic
hygroma and ascites. If possible, mutation analysis of
BRAF and MAP 2 K1 should also be considered
– If hydrops develops in addition to the hygroma, as
in the case described, prognosis is detrimental,
– The presence of partial, cutaneous syndactyly
involving digits 2–5 of the fingers and toes is very
rare and does not yet find a precise explanation. It is
however interesting to note that according to
Mazzaschi et al. [29] syndactyly has been described
in patients with a cell line containing a small marker
of X Chromosome origin .
Factors affecting the catch-up growth in preterm in-
fants are an important clinical issue [30]. Liu et al. [31]
in their interesting article address the important aspect
of recovery growth of preterm infants after discharge.
The authors based their analysis on the health belief
model, a social psychological health behavior change
model developed to explain and predict health-related
behaviors. The health belief model suggests that people’s
beliefs about health problems, perceived benefits of ac-
tion and barriers to action, and self-efficacy explain en-
gagement (or lack of engagement) in health-promoting
behavior [32]. In this study four dimensions of post dis-
charge feeding knowledge and six dimensions of
feeding-related health beliefs scores of preterm infants’
caregivers were considered and scored. Then, a logistic
regression analysis on several factors influencing the
catch-up growth of preterms infants after discharge has
been conducted. Studies involving preterm infants
showed that decreased gestational age and birth weight,
increase the incidence of extrauterine growth restriction
[33]. In comparison to two cited previous studies on
postnatal growth pattern of preterm newborns, in this
study the proportion of extremely low-birth-weight in-
fants was lower (1.3%). A catch-up growth, at 12 months
corrected age, has been not achieved in 17.4%, and was
related to gestational age, regular health care, mothers’
daily contact with the baby, caregivers’ educational
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background, monthly average family income, and
addition of breast milk supplements. Being small for ges-
tational age and very low birth weight have been recently
confirmed as risk factors for poor growth in another
study from China [34]. Key suggestions are given to in-
crease post discharge catch-up growth of preterms in-
fants. Among them, close post discharge health
monitoring and changes in social policies aimed at an
increased length of maternity leave, are of greater im-
portance. Interestingly, this study showed that the health
beliefs of caregivers had no significant effect on the
catch-up growth of preterm infants.
Infectious diseases. 1- hand washing; 2-
enterovirus; 3- osteomyelitis; 4- vaccines
Infections are one of the major causes of infant mortality
in developing countries. Human hands represent an im-
portant vehicle of pathogen transmission by touching
nose, mouth, or eyes. Dagne et al. [35] performed a
questionnaire community based cross-sectional study in
Debark town (Ethiopia). A good hand washing practice
was found in 52% of mothers of under five children and
the most significant associated factors were knowledge,
attitude, and water availability. In another study con-
ducted in Northwest Ethiopia [36]. Mothers had good
handwashing knowledge in 66.05% of instances. Children
who had mothers with good handwashing knowledge
were 51% less likely to have diarrhea than those with
mothers of poor knowledge. Literacy, level of education,
economic status, and social norms played a crucial role
in preventing children infections. The results of these
studies are confirmed by Taddese et al. [37] who
assessed handwashing in under-five children admitted at
an Ethiopian hospital. Handwashing was correctly per-
formed by 39.1% of mothers. Poor hygienic practices can
influence diarrheal admissions among under-five
children.
Enteroviruses are RNA viruses belonging to the family
Picornaviridae, that are transmitted from person to per-
son via fecal-oral or respiratory routes. Enteroviral infec-
tions are spread worldwide and show a seasonal pattern
with a peak during summer. Clinical manifestation may
vary according to the age of presentation [38] from
asymptomatic or mild and self-limited disease to more
severe infections especially in neonates and young in-
fants. Severe enteroviral diseases in neonates include
hepatic necrosis with coagulopathy, meningoencephal-
itis, and myocarditis [39]. Moreover, enterovirus is one
of the primary causes of central nervous system infec-
tions in childhood [40].
Berardi et al. [38] analyzed clinical manifestation of
enteroviral infection comparing infants younger and
older than 90 days. They found that fever was common
in both groups, cutaneous rash and seizure were
predominant among younger children, whereas neck ri-
gidity, vomiting and diarrhea were more frequent among
older ones. Moreover, cerebrospinal fluid pleocytosis
and increased white cell count were more characteristic
of older infants.
Knowledge of the clinical syndromes allows physicians
to early identify potential severe cases and to perform
diagnostic tests to readily start appropriate treatment [39].
Since enteroviral central nervous system infection may
cause possible neurologic sequelae, neurodevelopmental
follow-up should be planned in these patients [38].
Brodie’s abscess is a subacute hematogenous osteomye-
litis characterized by a low-grade pyogenic abscess with
milder clinical features than the acute form. The treatment
of Brodie’s abscess may vary. Successful treatment is fre-
quently achieved with prolonged parenteral administration
of antibiotics associated with immobilization, though thus
some patients require curettage [41]. Local gentamicin-
PMMA beads implantation can also be used. Cossio et al.
[42] described a 2-years-old male with Brodie’s abscess of
the distal diaphysis of tibia. First, he unsuccessfully treated
with oxacillin for 20 days. He then received rifampicin and
levofloxacin that was immediately halted because of allergic
reactions. Subsequently, trimethoprim sulfamethoxazole
was introduced and then interrupted because of leukopenia,
followed by oral rifampicin and doxycycline. After 2months
of treatment, magnetic resonance imaging showed no im-
provement of the bone lesion. The patient underwent to
surgical treatment with bioactive glass BAG-S53P4, a bone
substitute with antibacterial properties and a good safety
profile. Seventeen months later the patient was free of in-
fection and presented a complete recovery. The BAG-
S53P4 did not affect the growth. However, it is important
to extend the clinical and the radiographic follow up
through the weight-bearing radiographs in children with
sub-acute osteomyelitis of the lower limb since Brodie’s ab-
scess can result in growth deformities [43]. These problems
may also develop many years after the bone injury.
Healthcare workers (HCWs) have an important role in
informing, advising, and promoting vaccinations. They
are also particularly exposed to vaccine-preventable dis-
eases and their vaccination is important to reduce dis-
ease transmission to other members of staff and their
patients, particularly the vulnerable groups. Tomboloni
et al. [44] performed an observational study with the aim
to detect the knowledge, skills, attitude, and barriers of
HCWs regarding vaccination in a tertiary children’s hos-
pital in Italy. At variance from other recent studies [45]
who identify gaps in knowledge as the leading cause of
the decrease of vaccination coverage among HCWs,
Tomboloni et al. suggest that this effect is due to a low
perception of risk associated with the disease rather than
lack of knowledge. However, their statement is only
based on data regarding flu vaccine. Along the same
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lines Di Martino et al. also considered the main reason
for missing flu vaccination was the presumed uselessness
of the vaccine [46]. In another research [47] it was ob-
served that the anti-influenza vaccination coverage of
HCWs in Italy is far below the minimum targets set.
The authors consider the informative role of the occupa-
tional physicians as fundamental to increase the aware-
ness of the potential of the flu vaccine. Di Martino et al.
[46] also suggest taking advantage of COVID-19 epi-
demic to sensitize the population and the HCWs about
flu vaccination. In particular, flu vaccination could facili-
tate the differential diagnosis in cases of new COVID-19
outbreak during the next winter season. So, the Italian
Government strongly recommended the flu vaccine in
2020 for the pediatric population between 6months and
6 years of age in addition to the other risk category.
The role of HCWs in promoting vaccination is funda-
mental in preterm infants, who due to their immature
immune system, are more vulnerable to vaccine-
preventable disease. It has been shown that preterm in-
fants, regardless of their degree of prematurity, have low
vaccination rates and delays [48]. Possible reasons [48]
include parental and provider perception of medical vul-
nerability, lack of information on vaccine recommenda-
tion and concerns about vaccine safety [49]. Hexavalent
vaccines protect against diphtheria, tetanus, pertussis,
poliovirus, hepatitis B virus, Haemophilus influenzae and
are routinely administered in most European countries.
Hexavalent vaccines in Italy should be administered in
preterm infants with the same schedule of term babies
[50–52]. An updated joint document by Italian Society
of Pediatric Allergy and Immunology jointly with the
Italian Society of Neonatology on hexavalent vaccines in
preterm infants has been published [50]. Regarding the
safety of hexavalent vaccines, an increased incidence of
apnoea, bradycardia, desaturation occurs in preterm in-
fants in 48 h following injection. Apnoea episodes develop
in preterm infants with most severe clinical conditions
who required continuous positive airway pressure, and
who have had similar episodes, especially within 24 h prior
to the injection. Therefore, preterm babies who are still
hospitalized should receive the first dose of vaccine during
the hospitalization, particularly if they present risk factors
for adverse events [50]. Similarly, in the most severe pre-
term infants (< 28 weeks) or those with a recent history of
respiratory distress, vaccine should be administered at
hospital and patients should be monitored for 2 or 3 days.
Risk factors for recurrence of post-vaccination apnoea are
birth weight < 2 kg, gestational age ≤ 31 weeks, age < 67
days, previous similar episodes, and hospitalization for
condition associated with prematurity. Infants at risk of
recurrence should get the second dose under medical
supervision in a setting with facilities for treating adverse
reactions and should be monitored for 48–72 h.
Gastroenterology. 1- cholestatic jaundice
The clinical diagnosis of neonatal cholestasis is consid-
ered an extremely challenging process. In their commen-
tary, Mandato et al. [53] have highlighted not only the
importance of a prompt distinction between extrahepatic
and intrahepatic cholestasis, but also underlined the role
of the correct identification of the latter amongst the
hotchpotch of the recently discovered metabolic/genetic
causes.
The diagnosis is based on anamnestic and clinical ele-
ments, as well as on laboratory and instrumental data.
As far as the clinical features, in addition to jaundice, pa-
tients may present with symptoms or signs that are con-
sidered as red flags including hyperchromic urines,
hypocholic or acholic stools, and incipient itching. For
the laboratory evaluation, the American Academy of
Pediatrics and the North American and European Asso-
ciations for Pediatric Gastroenterology, Hepatology and
Nutrition recommend that infants with jaundice lasting
more than 2–3 weeks are tested for both serum conju-
gated and total bilirubin, and are evaluated by an expert
as soon as possible [54, 55].
Neonatal cholestasis may stem from several condi-
tions. The archetypal types of exclusive/prevalent extra-
hepatic cholestasis are biliary atresia and choledochal
cyst [56]. Biliary atresia is considered a surgical emer-
gency in newborns. The rate of success in establishing
bile drainage is in fact a function of the early age when
the hepato-portoenterostomy intervention is made.
Intrahepatic cholestasis is due to a broad and more and
more puzzling variety of infectious, endocrine, genetic,
metabolic, and toxic disorders, whereas the gamma-
glutamyl transpeptidase serum levels may help for the
differential diagnosis. Recently established laboratory
diagnostic techniques have allowed to discover new
causes of neonatal cholestasis. In this regard, the group
of Pinon and co-workers reported on another syndromic
condition characterized by cholestasis, due to a hepatic
picture of paucity of intralobular bile ducts combined
with renal involvement and paved the way to the inclu-
sion of the hepatocyte nuclear factor-1-beta deficiency
as a new condition to be considered in the diagnostic
process of the syndromic forms with paucity of intralob-
ular bile ducts [57].
Neonatology. 1- neonatal emergency transport; 2-
skin-to-skin contact; 3- non-invasive ventilation;
4- low birth weight; 5-sepsis
The benefits and effects of skin-to-skin contact and
breast-feeding immediately after birth, are widely known.
They include an enhanced frequency and length of
breast feeding, the maintenance of glycemia and
temperature, the cardio-respiratory stability in preterm
newborns, the improved maternal attachment behaviour
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and decreased crying [58]. However, early skin-to-skin
contact is rarely associated with sudden unexpected
postnatal collapse that can have serious outcomes [59].
The importance of early skin-to-skin contact after birth,
as well as the inherent risk factors that may cause sud-
den unexpected postnatal collapse led to the necessity of
evaluating how reduce the risk of its occurrence. Barba-
glia et al. conducted a questionnaire study on skin-to-
skin contact and delivery room practices in a longitu-
dinal survey which compared hospital data collected in
2012 and in 2016 in 2 regions of Northern Italy [60].
The survey showed the efforts in promoting early skin-
to-skin contact after birth in the wards. However, it
highlighted several aspects that favour the occurrence of
sudden unexpected postnatal collapse. Regulation of the
timing and length of skin-to-skin contact and how it was
performed were lacking. Vital signs during early skin-to-
skin contact were routinely recorded in only about 30%
of wards in 2012, in 50% in 2016. Written procedures
were available in a minority of wards (12/28 in 2012 and
10/26 in 2016). Mother-baby dyads were continuously
observed in nearly half of the wards. Authors believe
that surveys at regular intervals may permit identifying
changes to be made to have safer skin-to-skin care birth
centres.
Until now, the European Community rules have speci-
fied the requirements for the design, testing, perform-
ance, and equipping of the road ambulance used for the
transport and care of injured or ill adults, completely ig-
noring the neonatal transport. Bellini et al. describe in
detail a novel project aimed to realize a dedicated
ground ambulance for the neonatal emergency transport
service [61] avoiding fitting an ambulance with superflu-
ous devices for adult use. They proposed that the cabi-
nets should contain essential equipment for the neonatal
transport, such as gloves and catheters box, the intub-
ation set, or central catheters, that are usually stored
into the transport bag, thus being immediately available
and easily transportable. They demonstrated that it is
not possible to simply adapt the currently dedicated am-
bulance for mobile intensive care and resuscitation ser-
vices (actual type C European Community) in a modern
ambulance for emergency transport service. It is of para-
mount importance that the European Community intro-
duce an additional ambulance type, the type D,
exclusively reserved to transport neonates. Main differ-
ences between the European Type C ambulance and the
new proposed Type D neonatal ground ambulance are
the presence on board of several devices such as the air
compressed cylinder, iNO cylinders and delivery system,
the phototherapy lamp, shock adsorbing stretcher sup-
port, cooling device, a placenta refrigeration box and the
transcutaneous gas analyzer [61]. The current ambu-
lance configuration is far to the proposed ambulance
design. The hope is to re-think and re-design the avail-
able ambulance models to eventually integrate the EU
regulations adding the D ambulance model which is re-
served to the neonatal transport.
The deleterious consequences of the management of
neonatal respiratory distress syndrome (RDS) by invasive
ventilation have led to more in-depth investigation of
non-invasive ventilation (NIV) modalities. In their re-
view, Permall et al. [62] described and compared several
different modalities of NIV currently available, underlin-
ing strengths and limitations of each of them. Despite its
benefits in terms of survival of preterm infants, invasive
mechanical ventilation for the treatment of neonatal re-
spiratory disease has also resulted in an increased num-
ber of cases with bronchopulmonary dysplasia (BPD)
[63]. NIV has significantly and positively modified the
treatment outcomes and significantly improved the mor-
tality rates of preterm infants with RDS [64]. Among the
NIV modalities, the nasal intermittent positive pressure
ventilation (NIPPV) has shown considerable benefits
compared to nasal continuous positive airway pressure
(NCPAP) [65]. However, in one of the largest studies
ever published, Kirpalani et al. reported that NIPPV did
not prove to be superior to continuous positive air pres-
sure (CPAP) in extremely low birth weight (ELBW) in-
fants born before 30 weeks of gestation when outcomes
such as survival with BPD or death were considered
[65]. A recent addition to the NIV family in the neonatal
intensive care unit is the heated humidified high-flow
nasal cannula (HHHFNC), which delivers heated and
humidified gas through HFNC system [66]. Despite re-
ports of HHHFNC non-inferiority compared to NCPAP,
as shown by the HUNTER trial in Australia [67], other
trials have been terminated due to high treatment failure
rates with HHHFNC [68, 69]. Moreover, RDS manage-
ment with the combination of the INSURE (INtubation
SURfactant Extubation) technique and NIV ensures
higher success rates [70]. One of the latest innovative
method to deliver NCPAP is the neurally adjusted venti-
latory assist (NAVA) that can be used invasively and
non-invasively in spontaneously breathing infants [71]. It
is patient-controlled and is based on diaphragm elec-
trical activity to deliver synch. Although the long-term
effects of NIV-NAVA are still unknown, it is potentially
one of the NIV modes that may surpass the standard re-
spiratory support strategies in the next future.
Low birth weight (LBW) is one of the most important
risk factor for perinatal mortality, especially in develop-
ing countries [72]. In a cross-sectional study, Mekie
et al. described the magnitude of LBW and maternal risk
factors among women who delivered in Debre Tabor
Hospital, Ethiopia [73]. The LBW prevalence was 12.0%
[95%, CI: (8.5, 15.2%)]. It was similar with the prevalence
found in the Amhara Region, Ethiopia [74] but lower
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than that of the Ethiopia Demographic and Health Sur-
vey (EDHS) [75]. Place of residence, status of pregnancy,
and hemoglobulin < 11mg/dl [58] were found to be sig-
nificant associated with LBW [76] while women who lived
in urban areas, who had planned pregnancy, had lower
risk of delivering LBW babies. Limitations of the study in-
clude the cross-sectional design, in which recall bias may
occur, the involvement of one health facility with small
sample size which might affect generalizability. An inte-
grated approach should be followed to reduce the preva-
lence, morbidity and mortality related to LBW.
Neonatal sepsis is one of the leading causes of neo-
natal morbidity and mortality especially in developing
countries. Alemu et al. [77] investigated the determi-
nants of neonatal sepsis in 82 neonates with sepsis
(cases) with their index mothers and 164 neonates who
had no sepsis (controls) with their index mothers. Re-
sults show that both maternal and neonatal-related fac-
tors have a significant effect on the risk of neonatal
sepsis. This study reveals that while the premature rup-
ture of membrane was found to be an obstetric-related
determinant of neonatal sepsis, birth at gestational age
less than 37 weeks, not crying immediately at birth, and
resuscitation at birth were neonatal-related risk factors
of neonatal sepsis. According to this study, preterm deliv-
ery is one of the most significant risk factors of neonatal
sepsis as it is 6.9 times more likely when compared to
term delivery. Moreover, neonatal sepsis among neonates
who not immediately crying at birth were 2.85 times more
likely as compared to those who were crying at birth [77].
This finding was in line with the previous findings in
Ghana [78]. Newborn might be unable to cry due to inter-
ference of respiration [79]. The absence of breathing and/
or crying might lead health care professionals to do resus-
citation that is significantly associated with neonatal sepsis
[80]. Indeed, since the study was done on admitted new-
borns, results might lack generalizability to the entire
population. However, it was confirmed that infection pre-
vention strategies need to be strengthened and/or imple-
mented by providing special attention to the specified
determinants [77].
Regarding the prevention of neonatal sepsis, probiotics
have been suggested to be of benefit [81]. In a double-
blinded randomized controlled study in formula-fed pre-
term infants, Cui et al. [82] demonstrated that Lactoba-
cillus reuteri DSM 17938 did not reduce occurrence of
sepsis, localized infection or necrotizing enterocolitis.
However, it significantly reduced both severity and num-
ber of gastroesophageal reflux episodes, duration of full
enteral feeding, improved early feeding tolerance and in-
creased body weight, length, and head circumference.
They also confirmed [83] that Lactobacillus reuteri en-
hanced daily defecation frequency and reduced hospital
stays, without adverse effects. This is worthwhile since
preterm infants have poor sucking and swallowing abil-
ities, immature digestive systems, insufficient gastro-
intestinal motility, and low gastrointestinal mucosal
barrier function [84]. Moreover, they are prone to feed-
ing intolerance such as regurgitation, vomiting, abdom-
inal distension, and gastric retention during feeding. A
prominent condition among preterm infants is gastro-
esophageal reflux. When severe, symptoms such as ap-
noea, bradycardia, vomiting, poor weight gain and
irritability have been attributable to gastroesophageal re-
flux disease.
Antibiotics are the cornerstone of treatment of neo-
nates with sepsis [85]. Pentoxifylline is a nonsteroidal
immunomodulating agent which has been used in sev-
eral infectious, vascular, and inflammatory diseases in
children [86]. Pentoxifylline is also used to treat neonatal
sepsis [85]. A meta-analysis of 7 randomized controlled
studies involving 439 newborns on the efficacy of pen-
toxifylline treatment for neonatal sepsis in China was
carried out by Tian et al. [87]. Results of the meta-
analysis demonstrated that pentoxifylline treatment had
a positive impact reducing hospital stay and metabolic
acidosis [85]. However, pentoxifylline provided no bene-
fit on mortality for neonatal sepsis, disseminated intra-
vascular coagulopathy and oliguria/anuria. The study by
Tian et al. [87] had indeed several potential limitations
that should be taken into account. The analysis included
only 7 randomized controlled studies and 5 of them had
small sample size (n < 100). Overestimation of the treat-
ment effect is more likely in smaller trials compared
with larger samples. Therefore, the heterogeneity of
mortality in this meta-analysis was possibly caused by
different schedules of pentoxifylline treatment.
Neurology. 1- malignant spinal cord compression
Malignant spinal cord compression (MSCC) is one of
the most feared complications of pediatric spinal cancer
[88]. It is associated with poor prognosis as permanent
paralysis, sensory loss, and sphincter dysfunction may
develop. Very limited data are available on both inci-
dence and etiology of MSCC in the pediatric population.
To assess etiology, clinical presentation, and treatment
of MSCC De Martino et al. evaluated retrospectively 44
pediatric patients with symptomatic MSCC who have
been admitted to a children hospital since 2007 [89].
The median age at time of MSCC diagnosis was 52
months, with a peak in young patients (≤3 years). During
the study period, the leading cause of MSCC in children
aged less than 18 years were the extramedullary tumors
(63.6%), in particular neuroblastoma (27.2%), followed
by the Ewing sarcomas (15.9%), thus confirming previ-
ous data [90, 91]. Cord compression was the presenting
feature of a new malignancy in 75% of patients. Motor
deficit was the initial symptoms of spinal compression in
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all patients, while pain was present in about 60% of
cases, followed by sphincteric deficit (43.2%), in accord-
ing with De Bernardi’s data [92]. The median length of
the interval between symptom onset and diagnosis
widely ranged from 0 to 360 days in the entire popula-
tion, however this interval was significantly shorter in
patients with known neoplasia in comparison to patients
with new diagnosis. Pre- and post-operative spine mag-
netic resonance imaging, i.e. the gold standard exam for
the diagnosis, was performed in all cases, and most pa-
tients (95%) underwent neurosurgical treatment as first
treatment. Treatment strategies differed widely among
cancer types and study groups in the absence of optimal
evidence-based treatment guidelines. It is well known
that when diagnosis is uncertain, surgery provides an op-
portunity to biopsy the lesion in addition to treating the
mass [93]. Patients with progression or relapsed disease
showed a worst prognosis, while most patients (70.5%)
were alive at 5 years after diagnosis. The natural history
of MSCC in children is associated to permanent paraly-
sis, sensory loss, and sphincter dysfunction, thus prompt
diagnosis and correct management are needed to
minimize morbidity [94].
Nutrition. 1- undernutrition
Undernutrition in developing countries is a main prob-
lem of public health. Gizaw et al. [95] performed a sys-
tematic review and metanalysis including 16.473
children to assess the role of single and combined water,
sanitation, and hygiene (WASH) intervention on nutri-
tional status and growth. The results showed that
WASH intervention significantly increased height-for-
age z score and improve children nutrition in under-2
years children compared to under-five ones. Moreover,
combined WASH interventions were more effective to
improve child nutritional status compared to single in-
terventions. This can be due to handwashing practice,
drinkable water availability, and the subsequent reduc-
tion in infectious diseases transmission. A recent met-
analysis conducted by Bekele et al. [96] confirmed that
WASH interventions alone improved height-for-age z-
score when delivered over 18–60months and for
children < 2 years. Integrated WASH with nutrition in-
terventions may be effective in improving child growth
outcomes. On the contrary, a trial conducted by Hum-
phrey et al. [97] tested the independent and combined
effects of improved WASH, and improved infant and
young child feeding on stunting and anaemia in Zim-
bawe showing that elementary WASH interventions im-
plemented in rural areas in developing countries are
might not be enough to reduce stunting or anaemia and
are might not be enough to reduce diarrhoea. Therefore,
some authors [98] highlighted the importance of access
to WASH as fundamental human right and although the
study by Humphrey et al. did not show short-term ef-
fects on stunting, it cannot be underestimate a substan-
tial intergenerational contribution to stunting. WASH in
maternal education remains a strong predictor of child
health outcomes, including stunting and nutrition.
Respiratory diseases. 1- cystic fibrosis; 2- air
pollution; 3- antibiotic prescriptions
Cystic fibrosis (CF) is the most common life-limiting
autosomal recessive disease among people of European
heritage that affects various organs of the body [99]. The
most important cause of death in CF patients is due to
lung involvement. Tabatabei et al. conducted a study to
isolate and identify Pandoraea species bacteria from
bronchoalveolar lavage and sputum samples of CF pa-
tients in Shiraz, Iran [100]. Pandoraea species are gram
negative, motile, non-spore forming, rod shaped and oxi-
dase positive, obligate aerobes bacteria, and have one
polar flagellum [101]. Most of Pandoraea species are as-
sociated with lung infections in CF patients. In this study
from 31 samples of bronchoalveolar lavage and sputum,
4 Pandoraea bacteria were isolated by culture method
and identified by CRP using specific primer, then anti-
biotic susceptibility was also evaluated. Antibiotic treat-
ment of infections caused by Pandoraea species is not as
easy because resistance against a wide range of antibi-
otics such as gentamicin, amikacin and imipenem has
been demonstrated and poor response to ciprofloxacin,
trimethoprim-sulfumethoxazole, piperacillin and tetra-
cycline is also frequently reported [102]. Conversely, an-
other group reported that P. sputorum is susceptible to
imipenem and resistant to meropenem [103]. This dis-
crepancy has already been described by several authors
and is due to the presence of meropenem-hydrolyzing β-
lactamase [103]. According to the current study, ability
to synthesize biofilm by Pandoraea isolates and resist-
ance to antibiotics are very important issues. Biofilm for-
mation indicates a protective mode of growth that
allows microorganisms to survive in hostile environ-
ments [104]. In this context it seems essential to under-
line the importance of the combined use of the two CRP
assays described for the identification of most Pandor-
aea species in bronchoalveolar lavage and sputum cul-
tures of CF patients in order to reduce the
misidentification of Pandoraea and the development of
antibiotic resistance in CF [104].
The impact of air pollution on respiratory health has
recently gained significant attention. Previous studies
have found a correlation between air pollutants and
multiple adverse effects on human health, in particular
respiratory and cardiovascular health. In their study,
Zhang et al. investigated the relationship between the air
pollutant concentrations in Suzhou City, China, and re-
spiratory tract infections in children of variable age
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caused by different pathogens using time series models
with lagged effects [105]. They collected the clinical data
from children hospitalized because of respiratory infec-
tions at a local Children’s Hospital during the years 2014
to 2016. They reported data from air quality measure-
ment in Suzhou City in the same period and showed
that PM2.5, PM10, NO2, SO2 and CO levels were signifi-
cantly associated with respiratory tract infections in chil-
dren under 3 years, with the largest effect sizes at a lag
of 3 weeks. Other studies suggested that the length of
this lag period may be greater for children under 5 years
of age than for older children [106]. Notably, the multi-
pollutant model found that PM2.5 level was significantly
associated with viral respiratory in children under 7
months, and with bacterial respiratory infections in
other age groups, while PM10 concentrations were asso-
ciated with viral infections in preschool children. In a
study conducted in Turin, Italy, Bono et al. showed an
association also between O3 concentrations and higher
numbers of emergency room visits by children present-
ing with respiratory problems [107]. The association be-
tween pollutant concentrations and viral and bacterial
respiratory infections was stronger among children
under 3 years than for older age groups, this being due
to the faster respiratory rate of infants and young chil-
dren, their immune system immaturity, and lower cap-
acity to synthesize antibodies. All these factors may lead
to greater susceptible to air pollutants. The PM2.5 and
the O3 levels have been demonstrated to have the stron-
gest influence on viral and Mycoplasma pneumoniae re-
spiratory infections when multiple pollutants were tested
together [105]. Taken together, these findings highlight
the need for prompt interventions aimed to reduce air
pollution, thus strengthening the importance of preven-
tion, diagnosis, and treatment of respiratory infections in
children.
Antimicrobials are the most widely prescribed drugs in
children worldwide and almost half of antibiotic pre-
scriptions in children are considered unnecessary [108].
Acute otitis media (AOM) and pharyngitis are two of
the most common infections in pediatrics, and a main
cause of antibiotic prescriptions [109]. Barbieri et al.
conducted an observational, retrospective, outpatient
study to describe the first-line treatment approaches to
AOM and pharyngitis in primary care settings in Italy
over 6 years [110]. Authors also included data about the
prevalence of ‘wait and see’ for AOM and the differences
in the prescriptions in cases with pharyngitis when the
diagnostic tests are used. The data were collected using
the Pedianet database that provides information from
children aged 0–14 in Italy. Authors identified 120,338
children followed by 125 family pediatricians between
January 2010 and December 2015 for a total of 923,780
person-years of follow-up. Of these, 30,394 children
(mean age 44months) received at least one diagnosis of
AOM (n = 54,943) and 52,341 (mean age 5 years) had at
least one diagnosis of pharyngitis (n = 126,098). A large
proportion of children with AOM (82.5%) were treated
with an antibiotic administered within 48 h. (mainly,
amoxicillin and amoxicillin/clavulanate) and the “wait
and see” approach was adopted only in 17.5% of cases.
Despite guidance to use the ‘wait and see’ approach in
the age group analyzed, this strategy is not often used
for AOM, as previously noted in other studies conducted
in hospital settings [111, 112]. Sixty-three percent cases
of pharyngitis were treated, and among these, Group A
β-haemolytic streptococcus pharyngitis, confirmed by
rapid test (56%), were treated with amoxicillin. The ones
not test-confirmed were treated with broad spectrum
antibiotics [110].
The trend over time shows an increase in the broad
spectrum antibiotic prescriptions in the last year (2015)
[113]. The results of this study confirm once again that diag-
nostic uncertainty of AOM and pharyngitis is one of the de-
terminants for antibiotics over prescription [114]. Finally,
authors also found that perceived parental expectations of an
antibiotic prescription and fear of under treatment is very
commonly, according to other studies [115].
Conclusions
In the second semester of year 2019, published papers
have revealed new insights that are immediately helpful
to improve care of children. They have enhanced our
understanding of prevalence, natural course, mecha-
nisms, symptoms, and treatment in many pediatric dis-
eases. Moreover, reported information pave the way for
further breakthroughs expected to improve diagnosis
and clinical management of diseases in childhood.
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